PROCEPT BioRobotics PRCT 深 沪
等待开盘 10-29 09:30:00 美东时间
36.95
+0.600
+1.65%
华盛通- 最 高37.28
- 今 开36.15
- 成交量 133.09万股
- 最 低 35.7475
- 昨 收 36.35
- 总市值 20.56亿
- 52周最高 103.8099
- 市盈率 静 --
- 换手率 2.39%
- 52周最低 32.1101
- 委 比 -22.19%
- 总股本 5563.59万
- 历史最高 103.8099
- 量 比 1.11
- 振 幅 4.22%
- 历史最低 15.38
- 每 手 1
- 风险率 18.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 贝莱德、花旗、摩根大通、富国银行均获上调目标价！汇丰上调超微公司目标价升至310美元
今日重点评级关注：Roth Capital：维持Cingulate"买入"评级，目标价从10美元升至17美元；JMP证券：维持BioCryst Pharma"跑赢大市"评级，目标价从17美元升至27美元
10-16 10:43
Beyond The Numbers: 4 Analysts Discuss PROCEPT BioRobotics Stock
Ratings for PROCEPT BioRobotics (NASDAQ:PRCT) were provided by 4 analysts in th...
10-16 06:00
Truist Securities Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $50
Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $64 to $50.
10-15 23:35
BTIG Reiterates Neutral on PROCEPT BioRoboticsto Neutral
BTIG analyst Ryan Zimmerman reiterates PROCEPT BioRobotics (NASDAQ:PRCT) from Neutral to Neutral.
09-16 18:28
Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts
Throughout the last three months, 4 analysts have evaluated PROCEPT BioRobotics...
09-03 05:00
Oppenheimer Upgrades PROCEPT BioRobotics to Outperform, Announces $60 Price Target
Oppenheimer analyst Suraj Kalia upgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Perform to Outperform and announces $60 price target.
09-02 20:22
PROCEPT BioRobotics shares are trading lower following the release of its Q2 financial results.
PROCEPT BioRobotics shares are trading lower following the release of its Q2 fi...
08-07 05:01
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Procept BioRobotics down after CEO retirement
Shares of Procept BioRobotics (NASDAQ:PRCT) fell ~9% on Friday after the surgical robotics company announced that its CEO, Reza Zadno, would retire effective Sept. 1, and Larry Wood, a member of the b...
07-25 23:23
PROCEPT BioRobotics Announces Preliminary Q2 Revenue Of ~$79.2M
SAN JOSE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (NASDAQ:PRCT) ("the Company"), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology,
07-25 06:05
